I agree this is good value and have a recently jumped on board myself. Considerable tailwinds for this company IMO:
- Ageing populations around the globe (sleep apnea is a function of age)
- Obese populations (sleep apnea is a function of obesity)
- Sleep apnea awareness: is really just starting to wake up (excuse the pun)
- Large overseas revenues: well positioned to benefit from falls in the $A (yes this goes both ways but personally I think $A will head south in coming years).
Reflected in good fundamentals, see picture. DYOR.
Undervalued, page-4
Add RMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$38.40 |
Change
-0.190(0.49%) |
Mkt cap ! $22.38B | |||
| Open | High | Low | Value | Volume |
| $38.40 | $38.58 | $38.30 | $19.94M | 518.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 906 | $38.39 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $38.49 | 313 | 1 |
View Market Depth
| Last trade - 16.10pm 29/11/2024 (20 minute delay) ? |
| RMD (ASX) Chart |
